SG Americas Securities’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

SG Americas Securities’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53,018	Closed	-$2.23M	–	3310
2023 Q2	$2.23M	Buy	53,018 +30,319	+134%	+$1.23M	0.02%	688
2023 Q1	$809K	Buy	22,699 +13,896	+158%	+$504K	0.01%	1306
2022 Q4	$323K	Sell	8,803 -11,561	-57%	-$457K	﹤0.01%	1868
2022 Q3	$960K	Buy	20,364 +11,039	+118%	+$713K	0.01%	1044
2022 Q2	$668K	Sell	9,325 -29,996	-76%	-$2.19M	0.01%	1691
2022 Q1	$3.18M	Buy	39,321 +29,150	+287%	+$2.47M	0.02%	632
2021 Q4	$1.04M	Buy	10,171 +6,222	+158%	+$597K	0.01%	1621
2021 Q3	$345K	Sell	3,949 -17,196	-81%	-$1.56M	﹤0.01%	2817
2021 Q2	$1.89M	Sell	21,145 -874	-4%	-$73.8K	0.01%	1160
2021 Q1	$1.67M	Sell	22,019 -32,559	-60%	-$2.45M	0.01%	1171
2020 Q4	$3.72M	Buy	54,578 +47,879	+715%	+$2.98M	0.02%	682
2020 Q3	$356K	Sell	6,699 -5,383	-45%	-$321K	﹤0.01%	1841
2020 Q2	$704K	Sell	12,082 -16,856	-58%	-$906K	0.01%	1759
2020 Q1	$1.14M	Buy	28,938 +16,633	+135%	+$973K	0.01%	1202
2019 Q4	$732K	Sell	12,305 -44,742	-78%	-$2.41M	0.01%	1489
2019 Q3	$3.04M	Sell	57,047 -23,435	-29%	-$1.2M	0.02%	688
2019 Q2	$4.11M	Buy	80,482 +23,454	+41%	+$1.09M	0.03%	636
2019 Q1	$2.95M	Sell	57,028 -35,336	-38%	-$1.71M	0.03%	645
2018 Q4	$3.63M	Buy	92,364 +53,111	+135%	+$2.47M	0.03%	504
2018 Q3	$2.02M	Sell	39,253 -40,926	-51%	-$2M	0.02%	1159
2018 Q2	$3.76M	Buy	80,179 +63,301	+375%	+$2.62M	0.03%	565
2018 Q1	$599K	Sell	16,878 -10,819	-39%	-$424K	﹤0.01%	1756
2017 Q4	$1.21M	Buy	27,697 +1,105	+4%	+$51.6K	0.01%	1238
2017 Q3	$1.39M	Sell	26,592 -40	-0.2%	-$2.23K	0.01%	1030
2017 Q2	$1.56M	Buy	26,632 +19,800	+290%	+$1.03M	0.01%	1074
2017 Q1	$313K	Sell	6,832 -13,256	-66%	-$660K	﹤0.01%	2148
2016 Q4	$1.06M	Buy	20,088 +12,683	+171%	+$614K	0.01%	1263
2016 Q3	$330K	Buy	+7,405	New	+$321K	﹤0.01%	2090
2016 Q2	–	Sell	-3,883	Closed	-$160K	–	3076
2016 Q1	$160K	Buy	+3,883	New	+$160K	﹤0.01%	2331

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SG Americas Securities's SYNH Position: Q3 2023 in Review

SG Americas Securities sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 53,018 shares — an estimated $2.23M sold.

SG Americas Securities first reported a position in SYNH in Q1 2016 and held it in 29 quarters. The position peaked at $4.11M in Q2 2019. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

SG Americas Securities reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
SG Americas Securities sold 53,018 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.23M.
SG Americas Securities first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 29 quarters.
SG Americas Securities's Syneos Health, Inc. Class A Common Stock position peaked at $4.11M in Q2 2019.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on SG Americas Securities's 13F filing for Q3 2023, filed 13 Oct 2023.